Clinical Trial Update: Abatacept Post-marketing Clinical Study in Japan [Phase 4]

View source ↗

Summary

Post-marketing Phase 4 study of abatacept in Japan for rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ORENCIA (ABATACEPT)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED